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It is now widely accepted that  people with diabetes are more likely to 
experience symptoms of depression compared with people without this chronic 
disease [1,2]. When diagnostic criteria are used (DSM-IV, ICD-10), the prevalence of 
depressive disorders in diabetes has been estimated at around 10%, which is twice as 
common as in the general population.  When self-report questionnaires are used the 
prevalence has been found to be even higher at 26%, suggesting that there are high 
rates of sub-threshold clinically significant psychological distress in diabetes 
populations [1].  
 However, recent findings indicate that the relationship between diabetes and 
depression is somewhat of an enigma.  For example, compared to the general 
population, the prevalence of depression does not seem greater in people who have 
undiagnosed diabetes [3]. Although the reasons for this discrepancy are currently 
unknown, it is possible that people who are unaware of having diabetes have fewer 
diabetes complications than those who have been formally diagnosed (diabetes 
complications are a risk factor for the development of depression,[4].   Alternatively, 
people unaware of having diabetes are also not cognizant of the full burden of caring 
for the condition.  Further research is clearly needed. 
The enigma of depression in diabetes becomes greater considering the fact that 
the incidence (number of new cases) of depression is not significantly higher than in 
the general population [5].  While good news for the majority of diabetes patients, it 
does confirm earlier observations for people with diabetes who have a history of 
depression, that the mood disorder is likely to last longer and/or recur more often in 
those who have diabetes [6]. A final piece of the enigma is that there is now firm 
evidence that depression increases the chances of developing diabetes with a recent 
meta-analysis [5] estimating the odds at 1.60 (1.37–1.88). 
 Whatever the nature of the relationship between the two conditions, 
depression in diabetes is associated with poorer self-care [7], impaired glycaemic 
control [8], an increased risk of developing diabetes-related complications, especially 
cardiovascular complications [9], increased mortality [10] and higher health care 
expenditure [11]. Although no UK data are available, studies in other  countries have 
shown total health care expenditure for individuals with diabetes and diagnosed with 
depression was 4.5 times higher than that for individuals without depression [12].  To 
put this into perspective, the lifetime cost of health care for patients with diabetes has 
been calculated to be more than double that for an equivalent non-diabetic population 
[13]. 
 Given these adversities, it is not surprising that clinical guidelines (including 
the UK General Practice Quality and Outcomes Framework) now recommend that all 
patients with diabetes undergo regular screening for .  Following an international 
symposium on depression and diabetes at the European Association for the Study of 
Diabetes (EASD) annual congress, and under the auspices of the Association for the 
Improvement of Mental Health Programme, a group of individuals from diverse 
global professional organizations (e.g.World Organisation of Family Doctors, World 
Psychiatric Association, International Council of Nurses, Psychosocial Aspects of 
Diabetes Study Group), came together to commit to working to improve outcomes for 
patients with co-morbid diabetes and depression. At this meeting the Dialogue on 
Diabetes and Depression was formed, and a diverse group of specialists and 
stakeholders agreed to work together in order to understand the current state of 
knowledge about diabetes and depression, and to set the agenda for future research 
and care in this field. To date, eight working groups have been formed and are 
currently bringing together evidence on the epidemiology, pathogenesis and treatment 
of co-morbid diabetes and depression.  
 Notwithstanding these international collaborative efforts, there are already 
some data indicating the efficacy of particular methods of identifying individuals with 
diabetes and depression. Case-finding instruments, such as the Center for 
Epidemiologic Studies Depression scale (CES-D, [14]) have proven to be effective in 
screening for depression in primary care settings [15], and also to be suitable for use 
in people with diabetes [16].  
 Whilst routine administration of depression self-report questionnaires with 
feedback to physicians may not lead directly to increased intervention provision, the 
inclusion of a formal diagnosis along with provision of treatment support (e.g., 
knowledge and resources) may substantially increase the number of patients being 
treated for depression [17].  Whether treatment is sought and prescribed following 
feedback of depressive symptoms or diagnosis of major depressive disorder, depends 
on interactions between health-care provider, patient and context variables. General 
practitioners are more likely to refer for treatment or initiate treatment when 
depressive symptomatology is severe [18], or when psychological problems and 
major stressors are suspected (e.g., marital disruption, unemployment).  
Goals for treating depressed diabetes patients are two-fold: (1) remission or 
improvement of depressive symptoms; and (2) improvement of the often poor glycaemic 
control, which is generally considered as fundamental to the management of diabetes, 
in order to prevent or delay long-term complications. Treatment of depression may 
have a positive effect on levels of motivation to manage activities of daily living, to 
take physical exercise and to adhere to dietary management and medication regimes. 
However, there are only a handful of randomised controlled trials on the treatment of 
depression in people with diabetes and these are small-scale studies.  Results so far 
seem to suggest that cognitive behaviour therapy and anti-depressant medication are 
as effective in people with major depressive disorder (MDD) and diabetes as in those 
with MDD without diabetes, with, in some instances, additional beneficial effects on 
glycaemic control [19].  However, with over 10% of the diabetes population being 
depressed, a stepped treatment approach seems necessary to cope with the number of 
depressed people with diabetes. 
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